| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 3.573 | 4.867 | 8.842 | 30.021 | 6.749 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 3.573 | 4.873 | 8.848 | 30.282 | 6.750 | 6.445 |
| Total Expenses - EUR | 54 | 1 | 306 | 9.963 | 2.545 | 543 | 917 | 9.064 | 6.168 | 9.538 |
| Gross Profit/Loss - EUR | -54 | -1 | -306 | -9.963 | 1.029 | 4.330 | 7.931 | 21.219 | 582 | -3.092 |
| Net Profit/Loss - EUR | -39 | -1 | -306 | -9.963 | 921 | 4.194 | 7.670 | 20.447 | 189 | -3.092 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Syncreate Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.504 | 3.400 | 0 |
| Current Assets | -28 | -28 | -32 | -1 | 1.545 | 1.516 | 4.875 | 24.364 | 29.338 | 30.106 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.081 | 1.078 | 1.072 |
| Receivables | 0 | 0 | 0 | 8 | 1.545 | 1.516 | 4.896 | 22.867 | 28.031 | 28.085 |
| Cash | -28 | -28 | -32 | -9 | -1 | 0 | -21 | 415 | 230 | 949 |
| Shareholders Funds | -246 | -244 | -547 | -10.499 | -9.375 | -5.002 | 2.779 | 23.234 | 23.352 | 20.130 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 218 | 216 | 514 | 10.498 | 10.933 | 6.518 | 2.096 | 5.634 | 9.386 | 9.977 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7220 - 7220" | |||||||||
| CAEN Financial Year |
7220
|
|||||||||
Comments - Syncreate Health S.r.l.